|
Model Number SPL-PR376 |
Device Problem
Break (1069)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 09/29/2022 |
Event Type
malfunction
|
Event Description
|
Olympus reviewed the following literature titled "comparison of swiss lithoclast® trilogy and shockpulse-se as energy source in percutaneous nephrolithotomy for staghorn stones: a matched pair analysis." this study aimed to evaluate efficacy of swiss lithoclast trilogy (boston scientific, usa) and shockpulse-se (olympus) in pcnl for staghorn stones in 85 patients.Trilogy had 81.48 % clearance and shockpulse-se had 61.53% clearance at 48 hours in first stage pcnl.18.51% patients of trilogy and 38.46% patients of shockpulse-se required subsequent staged pcnl.Trilogy had 92.59% stone free rate at 3-month follow-up while shockpulse-se had 80.76% stone free rate.As per the study results, trilogy has comparable stone fragmentation rate with shockpulse-se in managing staghorn renal stones.Complications and instrument malfunction were also comparable for trilogy and shockpulse-s.Type of adverse events/number of patients: clavien-dindo grade-ii complications -3 (uti with fever).Malfunctions: suction block - 2, probe breaks - 3.This literature article requires 6 reports.The related patient identifiers are as follows: (b)(6).This medwatch report is for patient identifier (b)(6).
|
|
Manufacturer Narrative
|
Since the literature described "shockpulse-se", olympus selected "spl-pr376" as a representative product.The suspect device has not been returned to olympus for evaluation.The investigation is in process.The literature article doi: 10.1089/end.2022.36001.Abstracts provided for additional information.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
|
|
Manufacturer Narrative
|
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.Please see the corrections in e4 and g2 and the updates in h6 and h10.The device history record was unable to be reviewed for this device since the lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse event cannot be confirmed.Since the device was not returned for evaluation, the definitive root cause of the reported issue could not be determined.The following information is stated in the instructions for use (ifu): ¿page 22 of shockpulse instructions for use (spl-ifu_an) states, "the probe is fragile.It is critical that the surgeon does not bend or torque the probes against the endoscope during the procedure.There is no need to rotate the probe or transducer; it will not improve fragmentation or stone clearance."¿ olympus will continue to monitor field performance for this device.
|
|
Search Alerts/Recalls
|
|
|